| Literature DB >> 36173478 |
Anne Berghöfer1, Gabriele Rotter2, Joachim Pankert2, Katja Icke2, Stephanie Roll2, Ryan King2, Stefan N Willich2.
Abstract
During the COVID-19 pandemic, rehearsal and concert activities of professional orchestras and choirs were severely restricted based on the assumption of particularly high infection risks associated with wind instruments and singing. Therefore, our primary objective was to determine the incidence of SARS-CoV-2 infections in orchestra and choir musicians compared to controls. We also assessed influenza, flu, upper respiratory tract infections, and course of illness. Musicians from professional orchestras and choirs and controls from 23 institutions throughout Germany were included in a prospective cohort study. Data were collected from October 2020 to June 2021 by weekly online surveys. A mixed-effects cox proportional hazards model was used to assess the effect of exposure by professional activity on SARS-CoV-2 infection. In 1,097 participants (46.7 years (SD 10.3); 46.8% female; 705 orchestra, 154 choir, and 238 control subjects) 40 SARS-CoV-2 infections occurred. Cases per person-years were 0.06 in orchestras, 0.11 in choirs, and 0.03 in controls. Hazard ratios compared to controls were 1.74 (95% CI 0.58 to 5.25, p = 0.320) for orchestra musicians and 2.97 (0.87 to 10.28, p = 0.087) for choir singers. Infection source was suspected predominantly in private contexts. Disease courses were mild to moderate. Other respiratory infections were reported in 6.1% of study weeks in orchestras, 10.1% in choirs, and 8.0% in controls. Sick leave days of total study days were 0.5, 2.1 and 1.3%, respectively. This epidemiologic study during the pandemic in professional musicians indicates no increased risk of SARS-CoV-2 infections in orchestra musicians and a trend towards increased risk in choir singers compared to controls. However, the exact routes of infection could not be validated. If appropriate hygiene concepts are adhered to, safe orchestra and choir activity appears possible in pandemic times.Entities:
Keywords: Cohort study; Coronavirus SARS; Incidence; Occupational health
Year: 2022 PMID: 36173478 PMCID: PMC9519404 DOI: 10.1007/s10654-022-00917-x
Source DB: PubMed Journal: Eur J Epidemiol ISSN: 0393-2990 Impact factor: 12.434
Baseline characteristics by study group and in total. (SD standard deviation)
| Total N = 1,120 | Orchestra n = 723 | Choir n = 157 | Controls n = 240 | |
|---|---|---|---|---|
| Age, years, mean | 46.7 (10.4) | 47.4 (10.0) | 48.4 (9.2) | 43.6 (11.5) |
| Female | 520 (46.4) | 265 (36.7) | 104 (66.2) | 151 (62.9) |
| Male | 598 (53.4) | 458 (63.3) | 53 (33.8) | 87 (36.3) |
| Diverse | 2 (0.2) | 0 (0) | 0 (0) | 2 (0.8) |
| Single | 179 (16.0) | 87 (12.0) | 35 (22.3) | 57 (23.8) |
| Multi-person | 938 (83.8) | 634 (87.7) | 121 (77.1) | 183 (76.3) |
| Not specified | 3 (0.3) | 2 (0.3) | 1 (0.6) | 0 (0) |
| Number of children in household | 1.02 (1.12) | 1.11 (1.17) | 0.91 (0.99) | 0.79 (1.0) |
| Violin, viola | – | 276 (38.2) | – | – |
| Violoncello, double bass | – | 127 (17.6) | – | – |
| Plucked string instrument | – | 7 (1.0) | – | – |
| Wind instrument | – | 136 (18.8) | – | – |
| Brass instrument | – | 131 (18.1) | – | – |
| Percussion | – | 43 (5.9) | – | – |
| Not specified | – | 3 (0.4) | – | – |
| Soprano | – | – | 51 (32.5) | – |
| Alto | – | – | 49 (31.2) | – |
| Tenor | – | – | 23 (14.6) | – |
| Baritone | – | – | 26 (16.6) | – |
| Bass | – | – | 3 (1.9) | – |
| Not specified | – | – | 5 (3.2) | – |
| Stage staff | – | – | – | 41 (17.1) |
| Administration | – | – | – | 199 (82.9) |
| Influenza | 181 (16.2) | 94 (13.0) | 33 (21.0) | 54 (22.5) |
| Pneumococcus | 72 (6.4) | 44 (6.1) | 10 (6.4) | 18 (7.5) |
| Body-Mass-Index | 24.1 (4.2) | 23.9 (3.4) | 25.4 (5.4) | 24.0 (5.3) |
| Never | 704 (62.9) | 461 (63.8) | 108 (68.8) | 135 (56.3) |
| Currently smoking | 130 (11.6) | 80 (11.1) | 10 (6.4) | 40 (16.7) |
| Formerly smoking | 283 (25.3) | 179 (24.8) | 39 (24.8) | 65 (27.1) |
| Not specified | 3 (0.3) | 3 (0.4) | 0 (0) | 0 (0) |
| None | 818 (73.0) | 535 (74.0) | 106 (67.5) | 177 (73.8) |
| Arterial hypertension | 103 (9.2) | 62 (8.6) | 18 (11.5) | 23 (9.6) |
| Cardiac disease | 26 (2.3) | 17 (2.4) | 3 (1.9) | 6 (2.5) |
| Chronic bronchitis | 4 (0.4) | 2 (0.3) | 1 (0.6) | 1 (0.4) |
| Bronchial asthma | 49 (4.4) | 32 (4.4) | 5 (3.2) | 12 (5.0) |
| Other lung disease | 8 (0.7) | 4 (0.6) | 2 (1.3) | 2 (0.8) |
| Diabetes mellitus | 11 (1.0) | 6 (0.8) | 2 (1.3) | 3 (1.3) |
| Chronic liver disease | 1 (0.1) | 1 (0.1) | 0 (0) | 0 (0) |
| Cancer | 15 (1.3) | 8 (1.1) | 5 (3.2) | 2 (0.8) |
| Immunocompromized | 14 (1.3) | 6 (0.8) | 5 (3.2) | 3 (1.3) |
| Other | 149 (13.3) | 96 (13.3) | 26 (16.6) | 27 (11.3) |
Fig. 1A Professional exposure risk score in the exposed groups orchestra and choir. B Private risk score in all three study groups orchestra, choir, and controls
Fig. 2Cumulative incidence of SARS-CoV-2 infections per study group
SARS-CoV-2 Incidence in the total study cohort and in the three study groups orchestra, choir and controls; hazard ratios adjusted for mean private risk score
| Total N = 1,097 | Orchestra n = 705 | Choir n = 154 | Controls n = 238 | |
|---|---|---|---|---|
| SARS-CoV-2 positive cases | 40 | 26 | 10 | 4 |
| Weeks (years) under risk | 33,859 (651) | 21,993 (423) | 4,766 (92) | 7,100 (137) |
| Cases per person years | 0.06 | 0.06 | 0.11 | 0.03 |
| Number of person years per case | 16.3 | 16.3 | 9.2 | 34.1 |
| Hazard ratio | – | 1.74 | 2.97 | Ref |
| 95% confidence interval | – | 0.58 to 5.25 | 0.87 to 10.28 | – |
| p-value* | – | 0.320 | 0.087 | – |
*Compared to controls
Fig. 3A Proportion of participants with influenza, flu or other respiratory symptoms per week. B Proportion of participants with sick leave per week